“Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood And Marrow Transplant Clinical Trials Network Study.”. Blood 119 (16). Blood: 3854-60. doi:10.1182/blood-2012-01-403063.
. 2012. “Amphiregulin Modifies The Minnesota Acute Graft-Versus-Host Disease Risk Score: Results From Bmt Ctn 0302/0802.”. Blood Adv 2 (15). Blood Adv: 1882-1888. doi:10.1182/bloodadvances.2018017343.
. 2018. “Randomized Multicenter Trial Of Sirolimus Vs Prednisone As Initial Therapy For Standard-Risk Acute Gvhd: The Bmt Ctn 1501 Trial.”. Blood 135 (2). Blood: 97-107. doi:10.1182/blood.2019003125.
. 2020.